ミネソタ州における膀胱癌の臨床試験
ミネソタ州内の拠点で、膀胱癌に関する24件の研究が参加者を募集しています。
ミネソタ州内の都市
- Rochester12件の研究
- Minneapolis11件の研究
- Duluth6件の研究
- Saint Paul6件の研究
- Bloomington5件の研究
- Brooklyn Park3件の研究
- Plymouth3件の研究
公式研究テキスト（英語）
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Mayo Clinic in Rochester, Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- 他48件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Essentia Health - Deer River Clinic, Deer River
- Essentia Health Cancer Center, Duluth
- 他5件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06770582Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
- Mayo Clinic in Rochester, Rochester
被験者募集中第4相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06764095A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Health Partners Frauenshuh Cancer Center, Saint Louis Park
- Health Partners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Fairview Southdale Hospital, Edina
- Abbott-Northwestern Hospital, Minneapolis
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Essentia Health - Deer River Clinic, Deer River
- Essentia Health Cancer Center, Duluth
- Fairview Southdale Hospital, Edina
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Minnesota Oncology and Hematology PA, Minneapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Mayo Clinic (Rochester), Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Mayo Clinic Rochester, Rochester
- Minnesota Urology, Woodbury
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Minnesota Urology, Woodbury, Bloomington
- Mayo Clinic, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Minnesota Oncology - Burnsville, Burnsville
- Mercy Hospital, Coon Rapids
- Fairview Southdale Hospital, Edina
- 他16件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07097142Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/11更新 · NCT06891209LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- St. Luke's Hospital, Duluth
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Allina Health Cancer Institute - United Hospital, Saint Paul
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- 他2件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/08更新 · NCT07087860Bladder Bank (a Prospective Banking Study)
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/16更新 · NCT06109857cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Allina Health Cancer Institute, Minneapolis
- Mayo Clinic, Rochester
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Blue Light Cystoscopy With Cysview® Registry
- University of Minnesota, Minneapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duluth
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。